Literature DB >> 1445507

Clonal origin of bladder cancer.

D Sidransky1, P Frost, A Von Eschenbach, R Oyasu, A C Preisinger, B Vogelstein.   

Abstract

BACKGROUND: Patients with cancer of the urinary bladder often present with metachronous tumors, appearing at different times and at different sites in the bladder. This observation has been attributed to a "field defect" in the bladder that allows the independent transformation of epithelial cells at a number of sites. We tested this hypothesis using molecular genetic techniques.
METHODS: We examined 13 tumors from cystectomy specimens from four women, using a method that analyzes the pattern of X-chromosome inactivation to determine whether the tumors were derived from the same precursor cell. In addition, we analyzed allelic loss on autosomes to determine whether different tumors had the same genetic alterations. The alterations evaluated included the loss of chromosome 9q sequences (commonly found in superficial bladder tumors) and the loss of 17p and 18q sequences (usually found only in advanced tumors).
RESULTS: For each patient studied, all the tumors had inactivation of the same X chromosome, whereas normal bladder mucosa cells had random patterns of inactivation. Moreover, each tumor that could be evaluated from a given patient had lost the same allele on chromosome 9q, suggesting that the loss of this allele preceded the spread of neoplastic cells elsewhere in the bladder. The losses of chromosome 17p and 18q alleles, which are late events in tumor progression, were not common to different tumors from the same patient.
CONCLUSIONS: A number of bladder tumors can arise from the uncontrolled spread of a single transformed cell. These tumors can then grow independently with variable subsequent genetic alterations.

Entities:  

Mesh:

Year:  1992        PMID: 1445507     DOI: 10.1056/NEJM199203123261104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  83 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  The cellular ecology of progressive neoplastic transformation: a clonal analysis.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

Authors:  W A Franklin; A F Gazdar; J Haney; I I Wistuba; F G La Rosa; T Kennedy; D M Ritchey; Y E Miller
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

5.  Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.

Authors:  Qilai Long; Tzu-Yin Lin; Yee Huang; Xiaocen Li; Ai-Hong Ma; Hongyong Zhang; Randy Carney; Susan Airhart; Kit S Lam; Ralph W deVere White; Chong-Xian Pan; Yuanpei Li
Journal:  Nanomedicine       Date:  2018-01-06       Impact factor: 5.307

Review 6.  Early bladder cancer: concept, diagnosis, and management.

Authors:  Hiroshi Kitamura; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

7.  Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasms.

Authors:  Morgan Rouprêt; Pierre Colin
Journal:  World J Urol       Date:  2012-09-27       Impact factor: 4.226

Review 8.  Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers.

Authors:  Paul L Swiecicki; Julia R Brennan; Michelle Mierzwa; Matthew E Spector; J Chad Brenner
Journal:  Laryngoscope       Date:  2018-12-20       Impact factor: 3.325

9.  Synchronous colon carcinomas: molecular-genetic evidence for multicentricity.

Authors:  R J Koness; T C King; S Schechter; S F McLean; C Lodowsky; H J Wanebo
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

Review 10.  Molecular staging of head and neck squamous carcinoma.

Authors:  J A Brennan; D Sidransky
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.